Sign In

Login

Password

Forgot Password ? Sign Up

Mebendazol (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mebendazol" in Czech language version.

refsWebsite
Global rank Czech rank
19doi.org
2nd place
4th place
10worldcat.org
5th place
3rd place
1archive.org
6th place
10th place
1web.archive.org
1st place
1st place
1drugs.com
399th place
1,058th place

archive.org

doi.org

dx.doi.org

  • LACEY, E. Mode of action of benzimidazoles. Parasitology Today. 1990-04, roč. 6, čís. 4, s. 112–115. Dostupné online [cit. 2019-02-09]. ISSN 0169-4758. doi:10.1016/0169-4758(90)90227-u. 
  • MANN, David E. Goodman and Gilman's The Pharmacological Basis of Therapeutics: 6th Ed. Edited by Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. Macmillan, 866 Third Ave., New York, NY 10022. 1980. 1843pp. 18 × 26cm. Price $45.00. Journal of Pharmaceutical Sciences. 1981-05, roč. 70, čís. 5, s. 581. Dostupné online [cit. 2019-02-09]. ISSN 0022-3549. doi:10.1002/jps.2600700533. 
  • MAROSI, Christine. Faculty of 1000 evaluation for Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumors.. F1000 - Post-publication peer review of the biomedical literature [online]. 2017-11-08 [cit. 2019-02-09]. Dostupné online. 
  • NYGREN, Peter; FRYKNÄS, Mårten; ÅGERUP, Bengt. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. Journal of Cancer Research and Clinical Oncology. 2013-10-18, roč. 139, čís. 12, s. 2133–2140. Dostupné online [cit. 2019-02-09]. ISSN 0171-5216. doi:10.1007/s00432-013-1539-5. 
  • MARTARELLI, Daniele; POMPEI, Pierluigi; BALDI, Caterina. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Cancer Chemotherapy and Pharmacology. 2007-06-21, roč. 61, čís. 5, s. 809–817. Dostupné online [cit. 2019-02-09]. ISSN 0344-5704. doi:10.1007/s00280-007-0538-0. 
  • DOUDICAN, N.; RODRIGUEZ, A.; OSMAN, I. Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells. Molecular Cancer Research. 2008-08-01, roč. 6, čís. 8, s. 1308–1315. Dostupné online [cit. 2019-02-09]. ISSN 1541-7786. doi:10.1158/1541-7786.mcr-07-2159. 
  • LARSEN, A. R.; BAI, R.-Y.; CHUNG, J. H. Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor. Molecular Cancer Therapeutics. 2014-11-05, roč. 14, čís. 1, s. 3–13. Dostupné online [cit. 2019-02-09]. ISSN 1535-7163. doi:10.1158/1535-7163.mct-14-0755-t. 
  • BAI, Ren-Yuan; STAEDTKE, Verena; RUDIN, Charles M. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro-Oncology. 2014-09-24, roč. 17, čís. 4, s. 545–554. Dostupné online [cit. 2019-02-09]. ISSN 1523-5866. doi:10.1093/neuonc/nou234. 
  • MIZUNO, Katsuhiko; TOYODA, Yasuyuki; FUKAMI, Tatsuki. Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway. Archives of Toxicology. 2010-09-17, roč. 85, čís. 3, s. 199–207. Dostupné online [cit. 2019-02-09]. ISSN 0340-5761. doi:10.1007/s00204-010-0584-y. 
  • BLOM, Kristin; SENKOWSKI, Wojciech; JARVIUS, Malin. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation. Immunopharmacology and Immunotoxicology. 2017-05-04, roč. 39, čís. 4, s. 199–210. Dostupné online [cit. 2019-02-09]. ISSN 0892-3973. doi:10.1080/08923973.2017.1320671. 

doi.org

  • LACEY, E. Mode of action of benzimidazoles. Parasitology Today. 1990-04, roč. 6, čís. 4, s. 112–115. Dostupné online [cit. 2019-02-09]. ISSN 0169-4758. doi:10.1016/0169-4758(90)90227-u. 
  • MANN, David E. Goodman and Gilman's The Pharmacological Basis of Therapeutics: 6th Ed. Edited by Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. Macmillan, 866 Third Ave., New York, NY 10022. 1980. 1843pp. 18 × 26cm. Price $45.00. Journal of Pharmaceutical Sciences. 1981-05, roč. 70, čís. 5, s. 581. Dostupné online [cit. 2019-02-09]. ISSN 0022-3549. doi:10.1002/jps.2600700533. 
  • NYGREN, Peter; FRYKNÄS, Mårten; ÅGERUP, Bengt. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. Journal of Cancer Research and Clinical Oncology. 2013-10-18, roč. 139, čís. 12, s. 2133–2140. Dostupné online [cit. 2019-02-09]. ISSN 0171-5216. doi:10.1007/s00432-013-1539-5. 
  • MARTARELLI, Daniele; POMPEI, Pierluigi; BALDI, Caterina. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Cancer Chemotherapy and Pharmacology. 2007-06-21, roč. 61, čís. 5, s. 809–817. Dostupné online [cit. 2019-02-09]. ISSN 0344-5704. doi:10.1007/s00280-007-0538-0. 
  • DOUDICAN, N.; RODRIGUEZ, A.; OSMAN, I. Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells. Molecular Cancer Research. 2008-08-01, roč. 6, čís. 8, s. 1308–1315. Dostupné online [cit. 2019-02-09]. ISSN 1541-7786. doi:10.1158/1541-7786.mcr-07-2159. 
  • LARSEN, A. R.; BAI, R.-Y.; CHUNG, J. H. Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor. Molecular Cancer Therapeutics. 2014-11-05, roč. 14, čís. 1, s. 3–13. Dostupné online [cit. 2019-02-09]. ISSN 1535-7163. doi:10.1158/1535-7163.mct-14-0755-t. 
  • BAI, Ren-Yuan; STAEDTKE, Verena; RUDIN, Charles M. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro-Oncology. 2014-09-24, roč. 17, čís. 4, s. 545–554. Dostupné online [cit. 2019-02-09]. ISSN 1523-5866. doi:10.1093/neuonc/nou234. 
  • MIZUNO, Katsuhiko; TOYODA, Yasuyuki; FUKAMI, Tatsuki. Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway. Archives of Toxicology. 2010-09-17, roč. 85, čís. 3, s. 199–207. Dostupné online [cit. 2019-02-09]. ISSN 0340-5761. doi:10.1007/s00204-010-0584-y. 
  • BLOM, Kristin; SENKOWSKI, Wojciech; JARVIUS, Malin. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation. Immunopharmacology and Immunotoxicology. 2017-05-04, roč. 39, čís. 4, s. 199–210. Dostupné online [cit. 2019-02-09]. ISSN 0892-3973. doi:10.1080/08923973.2017.1320671. 

drugs.com

  • Mebendazole Monograph for Professionals - Drugs.com. web.archive.org [online]. 2015-09-07 [cit. 2019-02-09]. Dostupné v archivu pořízeném z originálu. 

web.archive.org

  • Mebendazole Monograph for Professionals - Drugs.com. web.archive.org [online]. 2015-09-07 [cit. 2019-02-09]. Dostupné v archivu pořízeném z originálu. 

worldcat.org

  • Encyclopedic reference of parasitology : diseases, treatment, therapy. 2. vyd. Berlin: Springer, 2001. xxi, 678 pages s. Dostupné online. ISBN 3540662391, ISBN 9783540662396. OCLC 45757751 
  • LACEY, E. Mode of action of benzimidazoles. Parasitology Today. 1990-04, roč. 6, čís. 4, s. 112–115. Dostupné online [cit. 2019-02-09]. ISSN 0169-4758. doi:10.1016/0169-4758(90)90227-u. 
  • MANN, David E. Goodman and Gilman's The Pharmacological Basis of Therapeutics: 6th Ed. Edited by Alfred Goodman Gilman, Louis S. Goodman, and Alfred Gilman. Macmillan, 866 Third Ave., New York, NY 10022. 1980. 1843pp. 18 × 26cm. Price $45.00. Journal of Pharmaceutical Sciences. 1981-05, roč. 70, čís. 5, s. 581. Dostupné online [cit. 2019-02-09]. ISSN 0022-3549. doi:10.1002/jps.2600700533. 
  • NYGREN, Peter; FRYKNÄS, Mårten; ÅGERUP, Bengt. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer. Journal of Cancer Research and Clinical Oncology. 2013-10-18, roč. 139, čís. 12, s. 2133–2140. Dostupné online [cit. 2019-02-09]. ISSN 0171-5216. doi:10.1007/s00432-013-1539-5. 
  • MARTARELLI, Daniele; POMPEI, Pierluigi; BALDI, Caterina. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Cancer Chemotherapy and Pharmacology. 2007-06-21, roč. 61, čís. 5, s. 809–817. Dostupné online [cit. 2019-02-09]. ISSN 0344-5704. doi:10.1007/s00280-007-0538-0. 
  • DOUDICAN, N.; RODRIGUEZ, A.; OSMAN, I. Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells. Molecular Cancer Research. 2008-08-01, roč. 6, čís. 8, s. 1308–1315. Dostupné online [cit. 2019-02-09]. ISSN 1541-7786. doi:10.1158/1541-7786.mcr-07-2159. 
  • LARSEN, A. R.; BAI, R.-Y.; CHUNG, J. H. Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor. Molecular Cancer Therapeutics. 2014-11-05, roč. 14, čís. 1, s. 3–13. Dostupné online [cit. 2019-02-09]. ISSN 1535-7163. doi:10.1158/1535-7163.mct-14-0755-t. 
  • BAI, Ren-Yuan; STAEDTKE, Verena; RUDIN, Charles M. Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro-Oncology. 2014-09-24, roč. 17, čís. 4, s. 545–554. Dostupné online [cit. 2019-02-09]. ISSN 1523-5866. doi:10.1093/neuonc/nou234. 
  • MIZUNO, Katsuhiko; TOYODA, Yasuyuki; FUKAMI, Tatsuki. Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway. Archives of Toxicology. 2010-09-17, roč. 85, čís. 3, s. 199–207. Dostupné online [cit. 2019-02-09]. ISSN 0340-5761. doi:10.1007/s00204-010-0584-y. 
  • BLOM, Kristin; SENKOWSKI, Wojciech; JARVIUS, Malin. The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation. Immunopharmacology and Immunotoxicology. 2017-05-04, roč. 39, čís. 4, s. 199–210. Dostupné online [cit. 2019-02-09]. ISSN 0892-3973. doi:10.1080/08923973.2017.1320671.